Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
GMDN
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
class
c5cb17a7-ba96-4850-8809-cafe91cda221
HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN Pharmacologic Class Indexing
Class set ID
c5cb17a7-ba96-4850-8809-cafe91cda221
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class
Mapped DailyMed Labels
#
Label, Manufacturer, Effective table
Label
Manufacturer
Effective
SPL version
These highlights do not include all the information needed to use ActHIB® safely and effectively. See full prescribing information for ActHIB. ActHIB [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] Solution for Intramuscular Injection Initial U.S. Approval: 1993
Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie
20260527
21
These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine for injectable suspension, for intramuscular use Initial U.S. Approval: 2008
Sanofi Vaccines US Inc. | Sanofi Vaccines Canada Ltd.
20260428
13
These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine Suspension for Intramuscular Injection Initial U.S. Approval: 2008
A-S Medication Solutions
20250516
1